Limits...
Current worldwide nuclear cardiology practices and radiation exposure: results from the 65 country IAEA Nuclear Cardiology Protocols Cross-Sectional Study (INCAPS).

Einstein AJ, Pascual TN, Mercuri M, Karthikeyan G, Vitola JV, Mahmarian JJ, Better N, Bouyoucef SE, Hee-Seung Bom H, Lele V, Magboo VP, Alexánderson E, Allam AH, Al-Mallah MH, Flotats A, Jerome S, Kaufmann PA, Luxenburg O, Shaw LJ, Underwood SR, Rehani MM, Kashyap R, Paez D, Dondi M, INCAPS Investigators Gro - Eur. Heart J. (2015)

Bottom Line: Patient radiation effective dose (ED) ranged between 0.8 and 35.6 mSv (median 10.0 mSv).The highest doses (median 12.1 mSv) and low QI (4.9) occurred in Latin America.The significant relationship between best-practice implementation and lower doses indicates numerous opportunities to reduce radiation exposure from MPI globally.

View Article: PubMed Central - PubMed

Affiliation: Division of Cardiology, Department of Medicine, Columbia University Medical Center and New York-Presbyterian Hospital, New York, NY, USA Department of Radiology, Columbia University Medical Center and New York-Presbyterian Hospital, New York, NY, USA andrew.einstein@columbia.edu.

No MeSH data available.


Related in: MedlinePlus

Worldwide distribution of patient radiation effective doses from myocardial perfusion imaging. Inset displays the distribution of patient effective doses by region.
© Copyright Policy - creative-commons
Related In: Results  -  Collection

License
getmorefigures.php?uid=PMC4493324&req=5

EHV117F1: Worldwide distribution of patient radiation effective doses from myocardial perfusion imaging. Inset displays the distribution of patient effective doses by region.

Mentions: Data were collected on all 7911 patients undergoing MPI in 308 laboratories in 65 countries, during the specified 1-week period. Mean patient age was 64.1 ± 12.0 years, and 41% were female. Mean ED for all patients was 10.0 ± 4.5 mSv. The distribution of patient ED showed a slight positive skew, with 978 patients (12%) receiving an estimated ED of >15 mSv (Figure 1). Both mean and median ED differed between laboratories (see Supplementary material online, Table S1), countries (see Supplementary material online, Table S2), and world regions (P < 0.001 for each). Worldwide, only 30% of laboratories had median ED ≤9 mSv. Adherence to best practices (Table 2) varied markedly between laboratories (mean QI score 5.4 ± 1.3), countries (see Supplementary material online, Table S2), and world regions (Table 3). Only 46% of laboratories adhered to six or more best practices.Table 2


Current worldwide nuclear cardiology practices and radiation exposure: results from the 65 country IAEA Nuclear Cardiology Protocols Cross-Sectional Study (INCAPS).

Einstein AJ, Pascual TN, Mercuri M, Karthikeyan G, Vitola JV, Mahmarian JJ, Better N, Bouyoucef SE, Hee-Seung Bom H, Lele V, Magboo VP, Alexánderson E, Allam AH, Al-Mallah MH, Flotats A, Jerome S, Kaufmann PA, Luxenburg O, Shaw LJ, Underwood SR, Rehani MM, Kashyap R, Paez D, Dondi M, INCAPS Investigators Gro - Eur. Heart J. (2015)

Worldwide distribution of patient radiation effective doses from myocardial perfusion imaging. Inset displays the distribution of patient effective doses by region.
© Copyright Policy - creative-commons
Related In: Results  -  Collection

License
Show All Figures
getmorefigures.php?uid=PMC4493324&req=5

EHV117F1: Worldwide distribution of patient radiation effective doses from myocardial perfusion imaging. Inset displays the distribution of patient effective doses by region.
Mentions: Data were collected on all 7911 patients undergoing MPI in 308 laboratories in 65 countries, during the specified 1-week period. Mean patient age was 64.1 ± 12.0 years, and 41% were female. Mean ED for all patients was 10.0 ± 4.5 mSv. The distribution of patient ED showed a slight positive skew, with 978 patients (12%) receiving an estimated ED of >15 mSv (Figure 1). Both mean and median ED differed between laboratories (see Supplementary material online, Table S1), countries (see Supplementary material online, Table S2), and world regions (P < 0.001 for each). Worldwide, only 30% of laboratories had median ED ≤9 mSv. Adherence to best practices (Table 2) varied markedly between laboratories (mean QI score 5.4 ± 1.3), countries (see Supplementary material online, Table S2), and world regions (Table 3). Only 46% of laboratories adhered to six or more best practices.Table 2

Bottom Line: Patient radiation effective dose (ED) ranged between 0.8 and 35.6 mSv (median 10.0 mSv).The highest doses (median 12.1 mSv) and low QI (4.9) occurred in Latin America.The significant relationship between best-practice implementation and lower doses indicates numerous opportunities to reduce radiation exposure from MPI globally.

View Article: PubMed Central - PubMed

Affiliation: Division of Cardiology, Department of Medicine, Columbia University Medical Center and New York-Presbyterian Hospital, New York, NY, USA Department of Radiology, Columbia University Medical Center and New York-Presbyterian Hospital, New York, NY, USA andrew.einstein@columbia.edu.

No MeSH data available.


Related in: MedlinePlus